MUSC Diagnostic Technologies


MUSC Diagnostic Technologies:


Methods for Detection of Pancreatic Cancer and other Cancers


Biomarker panel for Predicting Patient Response to Cardiac Resynchronization Therapy


Method of Formalin Fixed Paraffin Embedded Cell Block Preparation of Cytology Specimens


Urinary Biomarker of Renal Mitochondrial Dysfunction


Pseudo-Diaphragmatic Expansion Perfusion & Cryopreservation of Intact Viable Tissues


Biomarkers for Detecting and Monitoring Aortic Aneurysms


Assessing Left Ventricular Remodeling via Temporal Detection and Measurement of microRNA in Body Fluids


Biomarkers for Detecting Diastolic Heart Failure


Plasma Biomarkers for Predicting Recurrence of Atrial Fibrillation Following Cardioversion


Predicting Left Ventricular Dilation following Myocardial Infarction by Protease and Protease Inhibitor Profiling


Biomarkers for the Detection and Monitoring of Coronary Artery Disease


Biomarker for the Detection and Monitoring of Bladder Cancer


Use of Gene-Specific Priming for Reverse Transcription of RNA into DNA

Patent Information:
For Information, Contact:
Chelsea zzEx-Lubeskie
Licensing Manager, Devices
Zucker Institute of Innovation Commercialization powered by MUSC
© 2024. All Rights Reserved. Powered by Inteum